Three birds with one stone: Herein we report the discovery of pan‐PPAR agonists 6 and 9, which are based on the resveratrolscaffold and which have balanced EC50 values toward three PPAR subtypes, α, γ, and δ. We evaluated their biological activity in vivo and carried out dockingstudies as well.
[EN] FUROPYRIDINE COMPOUNDS AND USES THEREOF<br/>[FR] COMPOSÉS DE FUROPYRIDINE ET SES UTILISATIONS
申请人:NOVARTIS AG
公开号:WO2011131709A1
公开(公告)日:2011-10-27
The present invention provides a compound of formula (I); a method for manufacturing the compounds of the invention, and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.
PPARα agonists based on stilbene and its bioisosteres: biological evaluation and docking studies
作者:Barbara De Filippis、Mariangela Agamennone、Alessandra Ammazzalorso、Isabella Bruno、Alessandra D'Angelo、Mauro Di Matteo、Marialuigia Fantacuzzi、Letizia Giampietro、Antonella Giancristofaro、Cristina Maccallini、Rosa Amoroso
DOI:10.1039/c5md00151j
日期:——
A new series of gemfibrozil analogues conjugated with trans-stilbene were synthesized and evaluated with the aim of developing new PPARα agonists. The phenyls of stilbene were modified by introducing substituents in the ortho or para position and only the distal ring was substituted with naphthyl or heteroaromatic moieties, keeping the dimethylpentanoic skeleton of gemfibrozil unaltered. Two compounds